Malathi Anantha

1.2k citations

37 papers · 1.0k indexed · h-index 19

Impact in

Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems

Papers in ⓘ

Biomaterials 17
- Nanoparticle-Based Drug Delivery 17
Oncology 18
- Lung Cancer Research Studies 5
- Drug Transport and Resistance Mechanisms 5

Co-authors: Marcel B. Bally (36 shared papers)Murray S. Webb (6 shared papers)Mohamed Wehbe (13 shared papers)Katarina Edwards (7 shared papers)Nancy Dos Santos (5 shared papers)Ada W.Y. Leung (11 shared papers)Göran Karlsson (2 shared papers)Christine Allen (1 shared paper)
Journals: Journal of Controlled Release (6 papers)Cancer Research (6 papers)Drug Delivery and Translational Research (4 papers)Clinical Cancer Research (2 papers)Investigational New Drugs (2 papers)
Partner nations: Canada Sweden Netherlands

In The Last Decade

Malathi Anantha

36 papers receiving 1.0k citations

Peers

Countries citing papers authored by Malathi Anantha

Since Specialization

Citations

This map shows the geographic impact of Malathi Anantha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malathi Anantha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malathi Anantha more than expected).

Fields of papers citing papers by Malathi Anantha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malathi Anantha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malathi Anantha. The network helps show where Malathi Anantha may publish in the future.

Co-authors

The 25 scholars most cited alongside Malathi Anantha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Malathi Anantha Line = papers co-authored together Malathi Anantha links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding Biochimica et Biophysica Acta (BBA) - Biomembranes ·Nancy Dos Santos, Christine Allen, Anne-Marie Doppen, Malathi Anantha, Kelly A Cox, Ryan Gallagher, Göran Karlsson, Katarina Edwards, Gail S. Kenner, Lacey Samuels, Murray S. Webb, Marcel B. Bally	2007	292
2	Copper–topotecan complexation mediates drug accumulation into liposomes Journal of Controlled Release ·Amandeep Taggar, Jehan Alnajim, Malathi Anantha, A.M. Thomas, Murray S. Webb, Euan Ramsay, Marcel B. Bally	2006	59
3	Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent International Journal of Nanomedicine ·Mohamed Wehbe, Malathi Anantha, Minghan Shi, Ada W.Y. Leung, Wieslawa H. Dragowska, Léon Sanche, Marcel B. Bally	2017	58
4	Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development PLoS ONE ·Mohamed Wehbe, Malathi Anantha, Ian Backstrom, Ada W.Y. Leung, Kent Chen, Armaan Malhotra, Katarina Edwards, Marcel B. Bally	2016	46
5	Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine BMC Cancer ·Maïté Verreault, Dita Strutt, Dana Masin, Malathi Anantha, Andrew Yung, Piotr Kozłowski, Dawn Waterhouse, Marcel B. Bally, Donald T. Yapp	2011	44
6	Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats Journal of Nanobiotechnology ·Minghan Shi, Malathi Anantha, Mohamed Wehbe, Marcel B. Bally, David Fortin, Laurent-Olivier Roy, Gabriel Charest, Maxime Richer, Benoît Paquette, Léon Sanche	2018	43
7	Transition Metal-Mediated Liposomal Encapsulation of Irinotecan (CPT-11) Stabilizes the Drug in the Therapeutically Active Lactone Conformation Pharmaceutical Research ·Euan Ramsay, Jehan Alnajim, Malathi Anantha, Amandeep Taggar, A.M. Thomas, Katarina Edwards, Göran Karlsson, Murray S. Webb, Marcel B. Bally	2006	42
8	Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin Clinical Cancer Research ·Jennifer H.E. Baker, Jeffrey Lam, Alaistair H. Kyle, Jonathan Sy, Thomas S.N. Oliver, Steven J. Co, Wieslawa H. Dragowska, Euan Ramsay, Malathi Anantha, Thomas J. Ruth, Michael J. Adam, Andrew Yung, Piotr Kozłowski, Andrew I. Minchinton, Sylvia S. W. Ng, Marcel B. Bally, Donald T. Yapp	2008	41
9	A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer Journal of Controlled Release ·Mohamed Wehbe, Armaan Malhotra, Malathi Anantha, Jeroen Roosendaal, Ada W.Y. Leung, David Plackett, Katarina Edwards, Roger Gilabert‐Oriol, Marcel B. Bally	2017	38
10	Irinophore C: A Liposome Formulation of Irinotecan with Substantially Improved Therapeutic Efficacy against a Panel of Human Xenograft Tumors Clinical Cancer Research ·Euan C. Ramsay, Malathi Anantha, Jason Zastre, Marieke Meijs, Jet Zonderhuis, Dita Strutt, Murray S. Webb, Dawn Waterhouse, Marcel B. Bally	2008	33
11	Development of a copper-clioquinol formulation suitable for intravenous use Drug Delivery and Translational Research ·Mohamed Wehbe, Armaan Malhotra, Malathi Anantha, Cody Lo, Wieslawa H. Dragowska, Nancy Dos Santos, Marcel B. Bally	2017	32
12	Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting Properties Journal of Pharmaceutical Sciences ·Emmanuel A. Ho, Euan Ramsay, Mihaela Ginj, Malathi Anantha, Isaiah Bregman, Jonathan Sy, Janet Woo, Maryam Osooly-Talesh, Donald T. Yapp, Marcel B. Bally	2010	30
13	Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use Drug Delivery and Translational Research ·Kent T. J. Chen, Malathi Anantha, Ada W.Y. Leung, Jayesh A. Kulkarni, Gardenia G. C. Militao, Mohamed Wehbe, Brent W. Sutherland, Pieter R. Cullis, Marcel B. Bally	2019	29
14	Concomitant Chemoradiation Therapy with Gold Nanoparticles and Platinum Drugs Co-Encapsulated in Liposomes International Journal of Molecular Sciences ·Gabriel Charest, Thititip Tippayamontri, Minghan Shi, Mohamed Wehbe, Malathi Anantha, Marcel B. Bally, Léon Sanche	2020	26
15	Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C™) and 5-Fluorouracil PLoS ONE ·Jennifer I. Hare, Robert W. Neijzen, Malathi Anantha, Nancy Dos Santos, Natashia Harasym, Murray S. Webb, Theresa M. Allen, Marcel B. Bally, Dawn Waterhouse	2013	26
16	Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer Investigational New Drugs ·Nilesh A. Patankar, Dawn Waterhouse, Dita Strutt, Malathi Anantha, Marcel B. Bally	2012	24
17	Development and characterization of a novel flavopiridol formulation for treatment of acute myeloid leukemia Journal of Controlled Release ·Kent T. J. Chen, Gardenia G. C. Militao, Malathi Anantha, Dominik Witzigmann, Ada W.Y. Leung, Marcel B. Bally	2021	21
18	Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer Journal of Controlled Release ·Robert W. Neijzen, May Q. Wong, Navdeep Gill, He Wang, Tamanna Karim, Malathi Anantha, Dita Strutt, Dawn Waterhouse, Marcel B. Bally, Isabella T. Tai, Sylvia S. W. Ng, Donald T. Yapp	2014	20
19	Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor Journal of Controlled Release ·Ada W.Y. Leung, Malathi Anantha, Wieslawa H. Dragowska, Mohamed Wehbe, Marcel B. Bally	2018	19
20	Optimization of liposomal topotecan for use in treating neuroblastoma Cancer Medicine ·Lina Chernov, Rebecca Deyell, Malathi Anantha, Nancy Dos Santos, Roger Gilabert‐Oriol, Marcel B. Bally	2017	17

About Malathi Anantha

Malathi Anantha is a scholar working on Biomaterials, Oncology, Hepatology, Molecular Biology and Genetics, having authored 37 papers that have together received 1.0k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), Cancer therapeutics and mechanisms (8 papers), RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (5 papers), Lung Cancer Research Studies (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Nanoplatforms for cancer theranostics (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Biomaterials (518 citations), Pharmaceutical Science (62 citations), Molecular Biology (550 citations), Oncology (194 citations) and Biomedical Engineering (292 citations). Malathi Anantha has collaborated with scholars based in Canada, Sweden and Netherlands. Frequent co-authors include Marcel B. Bally, Murray S. Webb, Mohamed Wehbe, Katarina Edwards, Nancy Dos Santos, Ada W.Y. Leung, Göran Karlsson, Christine Allen, Ryan Gallagher and Lacey Samuels. Their work appears in journals such as Journal of Controlled Release, Cancer Research, Drug Delivery and Translational Research, Clinical Cancer Research and Investigational New Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact